Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Servier
Servier
Var2 Pharmaceuticals
IGM Biosciences, Inc.
TopAlliance Biosciences
Celgene
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sarcoma Alliance for Research through Collaboration
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Assaf-Harofeh Medical Center
Celldex Therapeutics
Rutgers, The State University of New Jersey
Valerio Therapeutics
Valerio Therapeutics
University of South Florida
INSYS Therapeutics Inc
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center